Back to NGNE

MPM BioImpact LLC → NGNE

MPM BioImpact LLC NGNE Position History

Neurogene Inc. • Healthcare

Quarters held
1
Latest value
$21.5M
Q3 2026
Peak value
$21.5M
First seen
Q3 2026

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$21.5M771.8K——

Other funds holding NGNE

Other MPM BioImpact LLC positions

CGEM

Cullinan Therapeutics, Inc.

$177.2M
AKTS

Aktis Oncology, Inc.

$155.9M
CGEM

Cullinan Therapeutics, Inc.

$149.2M
LQDA

Liquidia Corporation

$110.5M
DBVTF

DBV Technologies S A

$108.9M
CGEM

Cullinan Therapeutics, Inc.

$108.7M
AKTS

Aktis Oncology, Inc.

$94.2M
RVMDW

Revolution Medicines, Inc.

$92.2M